A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Appendiceal AdenocarcinomaColorectal

Interventions

PROCEDURE

Circulating tumoral DNA directed neoadjuvant therapy arm

Given by IV (vein)

Trial Locations (1)

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER